O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer

Identification of novel biomarkers is helpful for the diagnosis and treatment of cervical cancer. Mucin glycosylating enzyme GALNT2 modulates mucin O-glycosylation, and has been revealed as a regulator of tumorigenesis in various cancers. However, the expression pattern of GALNT2 in cervical cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Lixia, Wu, Huiqin, Bai, Xingli, Min, Shuyun, Zhang, Jiawen, Li, Cunli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469784/
https://www.ncbi.nlm.nih.gov/pubmed/36110252
http://dx.doi.org/10.3389/pore.2022.1610554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469784/
https://www.ncbi.nlm.nih.gov/pubmed/36110252
http://dx.doi.org/10.3389/pore.2022.1610554

Ejemplares similares